CN219423337U - Capsule with medicine slow-release function - Google Patents

Abstract

The utility model discloses a capsule with a medicine slow release function, which comprises a capsule body, wherein the capsule body comprises an enteric capsule main body, the enteric capsule main body comprises a first capsule shell and a first capsule cap detachably connected with the first capsule shell, a cage body formed by combining a plurality of spacing bars is arranged at the end part of the first capsule shell and/or the end part of the first capsule cap, a groove body communicated with the inside of the enteric capsule main body is arranged between adjacent spacing bars, and a gastric-dissolution wrapping cap is sleeved on the outer wall of the cage body. According to the enteric capsule, the end part of the enteric capsule main body is provided with the cage body provided with the plurality of groove bodies, the gastric-dissolution wrapping cap is wrapped outside the cage body, after the enteric capsule main body is swallowed, the capsule main body reaches the stomach first, gastric juice dissolves the gastric-dissolution wrapping cap outside the capsule main body, so that the groove bodies are exposed, medicines in the cage body can be slowly dissolved and released through the groove bodies, the medicine release speed is slowed down, the slow absorption is realized, and adverse reactions are avoided.

Description

Capsule with medicine slow-release function

[ field of technology ]

The utility model relates to the technical field of capsules, in particular to the technical field of capsules with a medicine slow-release function.

[ background Art ]

The capsule is a common article in modern medicine, and the medicine filled in the capsule is generally powder or granule which has irritation to esophagus and gastric mucosa, or is a medicine which has bad taste, is easy to volatilize, is easy to be decomposed by saliva in the oral cavity and is easy to be inhaled into the trachea. The medicines are filled into capsules, so that the medicine property is not destroyed, and the digestive organs and respiratory tract are also protected. Removing the capsule shell may result in loss of the drug, waste of the drug, and reduced efficacy. In addition, some drugs are required to be dissolved and absorbed in the intestines, and capsules protect the drugs from being damaged by gastric acid. The medicine refers to a capsule made of special film-forming materials (such as gelatin, cellulose, polysaccharide, etc.), and the content (such as powdery and liquid medicines, etc.) or the capsule is filled into the capsule according to dosage, so that the capsule is convenient to swallow. The existing capsules are divided into gastric-soluble capsules and enteric-soluble capsules, the gastric-soluble capsules can be dissolved in the stomach, the enteric-soluble capsules can be dissolved in the intestines, but the existing gastric-soluble capsules can be dissolved at a high speed once being dissolved, so that medicines are released at a high speed, and the absorption effect can be influenced even adverse reactions can be caused due to too high release speed of some medicines.

[ utility model ]

The utility model aims to solve the problems in the prior art and provides a capsule with a medicine slow-release function, which can reduce the medicine release speed.

In order to achieve the above purpose, the utility model provides a capsule with a drug slow release function, which comprises a capsule body, wherein the capsule body comprises an enteric capsule main body, the enteric capsule main body comprises a first capsule shell and a first capsule cap detachably connected with the first capsule shell, a cage body formed by combining a plurality of spacing bars is arranged at the end part of the first capsule shell and/or the end part of the first capsule cap, a groove body communicated with the inside of the enteric capsule main body is arranged between adjacent spacing bars, and a gastric-soluble wrapping cap is sleeved on the outer wall of the cage body.

Preferably, the width of the groove body is smaller than or equal to the diameter of the needed filling medicine.

Preferably, a second capsule body is further arranged in the enteric capsule body, and a second medicine cavity for filling medicine is arranged in the second capsule body.

Preferably, the second capsule body is a gastric-soluble capsule.

Preferably, the second capsule body is an enteric capsule.

Preferably, the cage is integrally formed with the first capsule shell or the first capsule cap.

The capsule with the medicine slow release function has the beneficial effects that: according to the enteric capsule, the end part of the enteric capsule main body is provided with the cage body provided with the plurality of groove bodies, the gastric-dissolution wrapping cap is wrapped outside the cage body, after the enteric capsule main body is swallowed, the capsule main body reaches the stomach, gastric juice dissolves the gastric-dissolution wrapping cap outside the capsule main body, so that the groove bodies are exposed, medicines in the cage body can be slowly dissolved and released through the groove bodies, the medicine release speed is slowed down, the slow absorption is realized, adverse reactions are avoided, and after the capsule main body flows to the intestinal tract, the residual enteric capsule main body and the medicines can be dissolved and absorbed, and residues are avoided.

The features and advantages of the present utility model will be described in detail by way of example with reference to the accompanying drawings.

[ description of the drawings ]

Fig. 1 is a schematic diagram showing the front view structure of a capsule with a drug sustained release effect according to the present utility model.

FIG. 2 is a schematic diagram showing the structure of a capsule with drug release function after dissolution of a gastric-coated cap according to the present utility model.

Fig. 3 is a schematic diagram showing the main structure of an enteric capsule body of a capsule with a drug sustained release effect according to the present utility model after dissolution of a gastric wrap cap.

[ detailed description ] of the utility model

The present utility model will be further described in detail with reference to the drawings and examples, in order to make the objects, technical solutions and advantages of the present utility model more apparent. It should be understood that the detailed description and specific examples, while indicating the utility model, are intended for purposes of illustration only and are not intended to limit the scope of the utility model. In addition, in the following description, descriptions of well-known structures and techniques are omitted so as not to unnecessarily obscure the present utility model.

In the description of the present utility model, it will be understood that when an element is referred to as being "fixed" or "disposed" on another element, it can be directly on the other element or be indirectly on the other element. When an element is referred to as being "connected to" another element, it can be directly connected to the other element or be indirectly connected to the other element.

In the description of the present utility model, it should be noted that the terms "center", "length", "width", "thickness", "upper", "lower", "front", "rear", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", and the like indicate orientations or positional relationships based on the orientations or positional relationships shown in the drawings, or orientations or positional relationships in which the inventive product is conventionally placed in use, are merely for convenience in describing the present utility model and simplifying the description, and do not indicate or imply that the apparatus or element to be referred to must have a specific orientation, be configured and operated in a specific orientation, and therefore should not be construed as limiting the present utility model. Furthermore, the terms "first," "second," "third," and the like are used merely to distinguish between descriptions and should not be construed as indicating or implying relative importance. Thus, a feature defining "a first" or "a second" may explicitly or implicitly include one or more such feature. In the description of the present utility model, the meaning of "a plurality" is two or more, unless explicitly defined otherwise. The meaning of "a number" is one or more than one unless specifically defined otherwise.

In the description of the present utility model, it should also be noted that, unless explicitly specified and limited otherwise, the terms "disposed," "mounted," "connected," and "connected" are to be construed broadly, and may be, for example, fixedly connected, detachably connected, or integrally connected; can be mechanically or electrically connected; can be directly connected or indirectly connected through an intermediate medium, and can be communication between two elements. The specific meaning of the above terms in the present utility model will be understood in specific cases by those of ordinary skill in the art.

Embodiment one:

referring to fig. 1, 2 and 3, the capsule with the medicine slow release function comprises a capsule body, wherein the capsule body comprises an enteric capsule main body 1, the enteric capsule main body 1 comprises a first capsule shell 11 and a first capsule cap 12 detachably connected with the first capsule shell 11, a cage body formed by combining a plurality of spacing bars 13 is arranged at the end part of the first capsule shell 11 and the end part of the first capsule cap 12, a groove body 14 communicated with the inside of the enteric capsule main body 1 is arranged between adjacent spacing bars 13, and a gastric-dissolution wrapping cap 2 is sleeved on the outer wall of the cage body. In this embodiment, the end of the enteric capsule main body 1 is set to be a cage body with a plurality of grooves 14, the outer part of the cage body is wrapped with the gastric-soluble wrapping cap 2, after the capsule is swallowed, the capsule main body reaches the stomach first, gastric juice dissolves the gastric-soluble wrapping cap 2 outside the capsule main body, so that the grooves 14 are exposed, the medicine in the cage body can be slowly dissolved and released through the grooves 14, the medicine release speed is slowed down, the medicine is slowly absorbed, adverse reaction is avoided, and when the capsule main body flows to the intestinal tract, the residual enteric capsule main body 1 and the medicine can be dissolved and absorbed by intestinal juice, so that residues are avoided.

Referring to fig. 1, 2 and 3, the width of the slot 14 is less than or equal to the diameter of the desired drug to be filled. So that the medicine can be slowly dissolved in the cage body.

Referring to fig. 1, 2 and 3, a second capsule body 3 is further disposed in the enteric capsule body 1, and a second medicine cavity for filling medicine is disposed in the second capsule body 3. The second capsule body 3 can be used for placing the same medicine or other medicines, when the same medicine is placed, the second capsule body 3 further prevents the medicine from releasing, and when different medicines are placed, the second capsule body 3 and the medicines in the enteric capsule main body 1 can be separated, so that the mutual reaction of the medicines is avoided.

Referring to fig. 1, 2 and 3, the second capsule body 3 is a gastric-soluble capsule.

Embodiment two:

preferably, the difference between the present embodiment and the first embodiment is that the second capsule body 3 is an enteric capsule in the present embodiment. The second capsule body 3 can be additionally provided with medicines suitable for intestinal absorption, so that the influence of premature release of the medicines on the using effect of the medicines is avoided.

Preferably, the cage body and the first capsule shell or the first capsule cap are integrally formed

The working process of the utility model comprises the following steps:

in the working process of the capsule with the medicine slow release function, after the capsule body is swallowed, the capsule body reaches the stomach, gastric juice dissolves the gastric-soluble coating cap 2 outside the capsule body, so that the groove body 14 is exposed, and medicine in the cage body can be slowly dissolved and released through the groove body 14, so that the medicine release speed is slowed down, and the medicine is slowly absorbed.

Standard parts used in the application file can be purchased from the market, the specific connection mode of each part adopts conventional means such as mature bolts, rivets and welding in the prior art, the electric sliding rail sliding seat, the air cylinder, the welding machine, the electric telescopic rod and the internal parts of the controller all adopt conventional models in the prior art, the internal structure of the electric sliding rail sliding seat belongs to the prior art structure, a worker can complete normal operation of the electric sliding rail sliding seat according to the prior art manual, and the circuit connection adopts the conventional connection mode in the prior art, so that specific description is not made.

It should be noted that, although the foregoing embodiments have been described herein, the scope of the present utility model is not limited thereby. Therefore, based on the innovative concepts of the present utility model, alterations and modifications to the embodiments described herein, or equivalent structures or equivalent flow transformations made by the present description and drawings, apply the above technical solutions directly or indirectly to other relevant technical fields, all of which are included in the scope of protection of the present patent.

Claims (6)

1. The capsule with the medicine slow release function comprises a capsule body and is characterized in that: the capsule body comprises an enteric capsule body (1), the enteric capsule body (1) comprises a first capsule shell (11) and a first capsule cap (12) detachably connected with the first capsule shell (11), a cage body formed by combining a plurality of spacing bars (13) is arranged at the end part of the first capsule shell (11) and/or the end part of the first capsule cap (12), a groove body (14) communicated with the inside of the enteric capsule body (1) is arranged between every two adjacent spacing bars (13), and a gastric-dissolution package cap (2) is sleeved on the outer wall of the cage body.

2. A capsule having a drug-releasing effect as claimed in claim 1, wherein: the width of the groove body (14) is smaller than or equal to the diameter of the needed filling medicine.

3. A capsule having a drug-releasing effect as claimed in claim 1, wherein: the enteric capsule is characterized in that a second capsule body (3) is further arranged in the enteric capsule main body (1), and a second medicine cavity for filling medicines is formed in the second capsule body (3).

4. A capsule having a drug-releasing effect as claimed in claim 3, wherein: the second capsule body (3) is a gastric-soluble capsule.

5. A capsule having a drug-releasing effect as claimed in claim 3, wherein: the second capsule body (3) is an enteric-coated capsule.

6. A capsule having a drug-releasing effect as claimed in claim 1, wherein: the cage body and the first capsule shell (11) or the first capsule cap (12) are integrally formed.